MedPath

The JOINT Study :Evaluation of effect and safty of Losartan/Hydrochlorothazide fixed dose combination for hypertensive patients

Phase 4
Conditions
Hypertension
Registration Number
JPRN-UMIN000001950
Lead Sponsor
Clinical practice of Hypertensive treatment study group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Patiens with renal failure(serum creatinine >2.5 mg/dL (2)Patients with liver dysfunction [GPT(ALT) over three times the normal value] (3)Pregnant or possible pregnant women (4)Breast-feeding women (5)Patients who are considered not eligible for the study by the attending doctor due to medical reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath